Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,230.00
-70.00 (-0.84%)
Last updated: Aug 24, 2026, 9:00 AM KST

KRX:007570 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
34,78523,6544,2953,4147,1749,288
Short-Term Investments
4,8735,9738,49510,2765,41934,111
Trading Asset Securities
-----231.78
Cash & Short-Term Investments
39,65829,62712,79013,69012,59343,631
Cash Growth
204.22%131.64%-6.57%8.72%-71.14%4.85%
Accounts Receivable
40,24244,97244,77747,65648,76252,803
Other Receivables
4,6413,9403,9364,6804,7163,297
Receivables
44,88348,91248,71352,33653,47956,101
Inventory
62,25664,24359,87353,10848,38732,423
Prepaid Expenses
541.32651.12158.02186.42303.23515.3
Other Current Assets
5,7384,3293,6524,3393,6563,671
Total Current Assets
153,076147,762125,187123,659118,418136,340
Property, Plant & Equipment
220,526220,675216,421181,973178,244175,779
Long-Term Investments
43,13040,67843,51038,57252,84745,029
Other Intangible Assets
1,7651,7121,8881,8261,9352,078
Long-Term Deferred Charges
24,50224,03923,45325,53029,48134,392
Other Long-Term Assets
22,54022,46420,56821,04621,99125,643
Total Assets
465,538457,331431,027392,607402,916419,261

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
19,69620,70422,32226,30729,81323,717
Accrued Expenses
440.78480.55513.8398.44310.58314.19
Short-Term Debt
82,80096,21692,50565,78971,00092,500
Current Portion of Long-Term Debt
3,3333,333--2,000-
Current Portion of Leases
445.43189.5266.59522.11370.52159.24
Current Income Taxes Payable
115.55236.41,2931,126958.543,542
Other Current Liabilities
57,15850,01240,64945,12140,87547,687
Total Current Liabilities
163,989171,172157,549139,263145,328167,920
Long-Term Debt
25,83326,66714,7006,000-5,000
Long-Term Leases
233.67388.51209.38339.24732.69843.73
Pension & Post-Retirement Benefits
7,1177,0188,5807,3227,9098,136
Long-Term Deferred Tax Liabilities
8,4058,2278,5659,23310,66210,464
Other Long-Term Liabilities
2,4302,4501,8915050021.5
Total Liabilities
208,008215,922191,494162,207165,132192,385

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
47,71447,71447,71447,71447,71447,714
Additional Paid-In Capital
78,37078,37078,37078,44178,41678,590
Retained Earnings
134,793122,790118,75953,55958,75943,170
Treasury Stock
-12,269-12,269-11,269-11,921-10,075-7,437
Comprehensive Income & Other
4,240-114.371,26457,95758,49660,587
Total Common Equity
252,848236,490234,838225,751233,311222,624
Minority Interest
3,5693,8053,5823,5363,3613,139
Shareholders' Equity
257,530241,409239,533230,400237,785226,876
Total Liabilities & Equity
465,538457,331431,027392,607402,916419,261

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
112,646126,794107,68172,65074,10398,503
Net Cash (Debt)
-72,988-97,168-94,891-58,960-61,511-54,872
Net Cash Growth
------
Net Cash Per Share
-4169.47-5414.14-5148.09-3272.13-3393.60-3014.10
Filing Date Shares Outstanding
17.9217.9218.0117.9718.0918.21
Total Common Shares Outstanding
17.9217.9218.0117.9718.0918.21
Working Capital
-10,913-23,410-32,362-15,604-26,910-31,580
Book Value Per Share
14105.9013193.3513036.8712561.4212899.4512228.63
Tangible Book Value
251,083234,778232,951223,925231,375220,547
Tangible Book Value Per Share
14007.4313097.8512932.0712459.7912792.4612114.49
Land
118,556118,556120,507120,298120,308116,955
Buildings
39,13939,55841,12642,78744,47445,995
Machinery
2,8392,9944,0556,0609,3679,480
Construction In Progress
58,59958,41549,58311,4352,3841,953